Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000532150 | SCV000536509 | likely benign | not provided | 2018-06-26 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000422155 | SCV000596765 | uncertain significance | not specified | 2015-08-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001084733 | SCV000656367 | likely benign | Norman-Roberts syndrome; Familial temporal lobe epilepsy 7 | 2024-12-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000532150 | SCV001155213 | uncertain significance | not provided | 2021-12-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001159160 | SCV001320848 | uncertain significance | Norman-Roberts syndrome | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Ambry Genetics | RCV002522719 | SCV003560995 | uncertain significance | Inborn genetic diseases | 2021-07-20 | criteria provided, single submitter | clinical testing | Unlikely to be causative of RELN-related lateral temporal epilepsy (AD) Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Diagnostic Laboratory, |
RCV000532150 | SCV001963147 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000532150 | SCV001975478 | uncertain significance | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004533137 | SCV004751443 | likely benign | RELN-related disorder | 2022-03-01 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |